ホーム › 腎臓がん（腎細胞がん） › カリフォルニア州 › Baldwin Park
Baldwin Park、CAにおける腎臓がん（腎細胞がん）の臨床試験
Baldwin Parkとその周辺地域（約30マイル以内）の拠点で、腎臓がん（腎細胞がん）に関する16件の研究が参加者を募集しています。研究を開いて、参加資格と連絡方法を確認してください。
公式研究テキスト（英語）
ここで研究参加者を募集していますか？ このページの上部に表示できます — 30日間 $99 →
Open-Label Phase 1/2 Study of NEO-811 in Subjects With Locally Advanced or Metastatic Non-Resectable Clear Cell Renal Cell Carcinoma
被験者募集中第1相
- NEO-811 Los Angeles Site, Duarte · 4マイル先
REGN15505 (PSMAx4-1BB) Alone or in Combination With Cemiplimab or REGN4336 (PSMAxCD3) in Adult Patients With Metastatic Castration-Resistant Prostate Cancer and Clear Cell Renal Cell Carcinoma
被験者募集中第1/2相
- City of Hope, Duarte · 4マイル先
Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer
被験者募集中第1/2相
- City of Hope (City of Hope National Medical Center, City of Hope Medical Center), Duarte · 4マイル先
- City of Hope Investigational Drug Services (IDS), Duarte · 4マイル先
A Study to Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies
被験者募集中第1相
- City of Hope Medical Center, Duarte · 4マイル先
Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer
被験者募集中第3相
- City of Hope Comprehensive Cancer Center, Duarte · 4マイル先
Positron Emission Tomography (PET) Guided Stereotactic Body Radiation Therapy for the Treatment of Oligoprogressive Non-small Cell Lung Cancer, Melanoma, and Renal Cell Carcinoma
被験者募集中第2相
- City of Hope Medical Center, Duarte · 4マイル先
Genetic Testing to Select Therapy for the Treatment of Advanced or Metastatic Kidney Cancer, OPTIC RCC Study
被験者募集中第2相
- City of Hope National Medical Center, Duarte · 4マイル先
Ivonescimab Prior to Surgery for the Treatment of High-Risk Localized Clear Cell Renal Cell Cancer
被験者募集中第2相
- City of Hope Medical Center, Duarte · 4マイル先
Study of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell Carcinoma
被験者募集中第1相
- Xencor Investigative Site, Duarte · 4マイル先
Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
被験者募集中第1/2相
- City of Hope, Duarte · 4マイル先
Immunotherapy (Nivolumab and Ipilimumab) With and Without a Live Biotherapeutic Product (EXL01) for the Treatment of Metastatic Renal Cell Cancer
被験者募集中第1相
- City of Hope Medical Center, Duarte · 4マイル先
Adding a Live Biotherapeutic Product (CBM588) to Pembrolizumab for the Treatment of Renal Cell Cancer After Surgery
被験者募集中第2相
- City of Hope Medical Center, Duarte · 4マイル先
Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
被験者募集中
- Beckman Research Institute of City of Hope, Duarte · 4マイル先
Light Therapy and Occupational Therapy Fatigue Management-Based Intervention for Patients With Genitourinary Cancers
被験者募集中
- City of Hope Medical Center, Duarte · 4マイル先
Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE Trial
被験者募集中第3相
- City of Hope Comprehensive Cancer Center, Duarte · 4マイル先
CBM588 Capsules in Combination With Nivolumab and Ipilimumab for the Treatment of Advanced Stage Kidney Cancer
被験者募集中第1相
- City of Hope Medical Center, Duarte · 4マイル先
他の都市における腎臓がん（腎細胞がん）の試験
- Houston, TX35件の研究
- New York City, NY27件の研究
- Nashville, TN23件の研究
- Dallas, TX23件の研究
- St. Louis, MO23件の研究
- Los Angeles, CA20件の研究
- Boston, MA16件の研究
- Philadelphia, PA15件の研究
- Pittsburgh, PA15件の研究
- Queens, NY15件の研究
- Jacksonville, FL14件の研究
- Cleveland, OH14件の研究
Baldwin Parkにおける他の研究
- 乳がん44件の研究
- 急性骨髄性白血病40件の研究
- 大腸癌37件の研究
- 非小細胞肺癌36件の研究
- がん（全種類）34件の研究
- 前立腺がん30件の研究
- 転移性癌30件の研究
- 骨髄異形成症候群26件の研究
- 卵巣がん25件の研究
- 肺がん24件の研究
- 多発性骨髄腫23件の研究
- 胃癌22件の研究
ClinicalTrials.govより、2026/10/06時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。